Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof

TW202634066APending Publication Date: 2026-08-16ALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115114403
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-18
Filing Date
2020-12-14
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073535_001
    Figure TWG2TA001073535_001
  • Figure TWG2TA001073535_002
    Figure TWG2TA001073535_002
  • Figure TWG2TA001073535_003
    Figure TWG2TA001073535_003
Patent Text Reader

Abstract

(PNPLA3) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a PNPLA3 gene and to methods of preventing and treating an PNPLA3-associated disorder, e.g., Nonalcoholic Fatty Liver Disease (NAFLD).
Need to check novelty before this filing date? Find Prior Art